Browse by author
Lookup NU author(s): Dr Claire WoodORCiD, Professor Volker StraubORCiD, Professor Michela GuglieriORCiD, Emerita Professor Katherine Bushby, Professor Timothy Cheetham
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Children with Duchenne muscular dystrophy (DMD) are shorter than their healthy peers. The introduction of corticosteroid (CS) has beneficial effects on muscle function but slows growth further and is associated with pubertal delay. In contrast to CS usage in most children and adolescents, weaning glucocorticoid is not a key objective of management in DMD. As the outlook for these young people improves, one of the main challenges is to reduce or offset the detrimental effects of CS on growth and development. This is a review of the aetiology and prevalence of short stature and delayed puberty in DMD, a summary of the treatments available and suggestions for areas of further research.
Author(s): Wood CL, Straub V, Guglieri M, Bushby K, Cheetham T
Publication type: Review
Publication status: Published
Journal: Archives of Disease in Childhood
Year: 2016
Volume: 101
Issue: 1
Pages: 101-106
Print publication date: 01/01/2016
Online publication date: 03/07/2015
Acceptance date: 16/06/2015
ISSN (print): 0003-9888
ISSN (electronic): 1468-2044
Publisher: BMJ PUBLISHING GROUP
URL: http://dx.doi.org/10.1136/archdischild-2015-308654
DOI: 10.1136/archdischild-2015-308654